Uploaded September 2020 | Updated November 2026, 1 hour ago
A new high-pressure ventilator developed by NASA engineers and tailored to treat coronavirus (COVID-19) patients was approved by the Food and Drug Administration (FDA) for use under the FDA's March 24 ventilator Emergency Use Authorization.
Called VITAL (Ventilator Intervention Technology Accessible Locally), the device was developed by engineers at NASA's Jet Propulsion Laboratory (JPL) in Southern California to free up the nation's limited supply of traditional ventilators so they may be used on patients with the most severe COVID-19 symptoms.
The Office of Technology Transfer and Corporate Partnerships at Caltech is offering a free license for VITAL and is reaching out to the commercial medical industry to find manufacturers for the device.
During the webinar, you will learn about the VITAL ventilator technology and how it can be licensed through NASA’s Technology Transfer Program.
A new high-pressure ventilator developed by NASA engineers and tailored to treat coronavirus (COVID-19) patients was approved by the Food and Drug Administration (FDA) for use under the FDA's March 24 ventilator Emergency Use Authorization.
Called VITAL (Ventilator Intervention Technology Accessible Locally), the device was developed by engineers at NASA's Jet Propulsion Laboratory (JPL) in Southern California to free up the nation's limited supply of traditional ventilators so they may be used on patients with the most severe COVID-19 symptoms.
The Office of Technology Transfer and Corporate Partnerships at Caltech is offering a free license for VITAL and is reaching out to the commercial medical industry to find manufacturers for the device.
During the webinar, you will learn about the VITAL ventilator technology and how it can be licensed through NASA’s Technology Transfer Program.







